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Innate lymphoid cells (ILCs) are a heteroge-
neous population of lymphocytes that lack 
antigen-specific receptors and respond to changes 
in the tissue cytokine microenvironment by se-
creting effector cytokines (Rankin et al., 2013a; 
Diefenbach et al., 2014; Artis and Spits, 2015; 
Eberl et al., 2015). Based on the cytokines secreted 
and transcription factors required for their de-
velopment, ILCs are divided into three major 
groups: ILC1s produce IFN- in response to 
IL-12, IL-15, and IL-18 and depend on T-bet 
for development; ILC2s secrete IL-5 and IL-13 
in response to IL-25, IL-33, and thymic stromal 
lymphopoietin (TSLP) and require GATA3, 
ROR, and Bcl11b; ILC3s produce IL-22, 
IL-17, and granulocyte macrophage-colony stim-
ulating factor (GM-CSF) when stimulated with 
IL-23 and/or IL-1 and require RORt and 
aryl hydrocarbon receptor (AHR). These major 
ILC groups are heterogeneous and include dis-
tinct subsets that more subtly differ in pheno-
type, transcriptional profile, tissue distribution, 
and developmental requirements (Robinette 
et al., 2015).
ILC3s have been associated with many im-
mune responses in the gastrointestinal tract. They 
provide defense against intestinal infections by 
various pathogenic bacteria, such as Citrobacter 
rodentium (C. rodentium). This protective effect is 
chiefly mediated by secretion of IL-22, which 
prompts epithelial cells to produce antimicrobial 
peptides that kill bacteria (Zheng et al., 2008; 
Tumanov et al., 2011; Guo et al., 2014), as well as 
fucosylated proteins that are shed in the intesti-
nal lumen and modify bacterial metabolism, 
thereby attenuating bacterial virulence (Pickard 
et al., 2014). ILC3s also promote intestinal ho-
meostasis in the steady state through multiple 
mechanisms. These include containing intestinal 
microbiota through IL-22 secretion (Sonnenberg 
et al., 2012), inducing T cell tolerance to bacterial 
antigens through MHC class II presentation 
(Hepworth et al., 2013; Hepworth et al., 2015), 
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Group 3 ILCs (ILC3s) are innate sources of IL-22 and IL-17 and include lymphoid tissue-
inducer (LTi)-like and NKp46+ subsets. Both depend on RORt and aryl hydrocarbon  
receptor, but NKp46+ILC3s also require Notch and T-bet for their development and are 
transcriptionally distinct. The extent to which these subsets have unique functions, espe-
cially in the context of T cell– and B cell–sufficient mice, remains largely unclear. To 
investigate the specific function of NKp46+ILC3s among other ILC3 subsets and T cells, we 
generated mice selectively lacking NKp46+ILC3s or all ILC3s and crossed them to T cell–
deficient mice, thus maintaining B cells in all mice. In mice lacking T cells, NKp46+ILC3s 
were sufficient to promote inflammatory monocyte accumulation in the anti-CD40 innate 
colitis model through marked production of GM-CSF. In T cell–competent mice, lack of 
NKp46+ILCs had no impact on control of intestinal C. rodentium infection, whereas lack of 
all ILC3s partially impaired bacterial control. Thus, NKp46+ILC3s have a unique capacity to 
promote inflammation through GM-CSF–induced accumulation of inflammatory monocytes, 
but are superseded by LTi-like ILC3s and T cells in controlling intestinal bacterial infection.
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ILC3s in vivo. To overcome this problem, we generated 
conditional knock-out mice in which AHR or RORt 
deficiency is restricted to RORt- and NKp46-expressing 
cells, respectively, obtaining mice that lack all ILC3 subsets or 
only NKp46+ILC3s. Moreover, these strains were crossed to 
a strain that lacks  and  T cells to evaluate ILC3 func-
tions in B cell–sufficient mice in the presence or absence 
of T cells.
We examined these mouse lines in two models of intesti-
nal inflammation, including a commonly used model of 
colitis and an infection model. The anti-CD40 model of 
colitis induces pathology caused by hyperactivation of innate 
immunity, but can only be used in immunocompromised 
mice (Uhlig et al., 2006). In this model, we found that ILC3s 
elicited robust inflammation and accumulation of pathogenic 
Ly6C+ inflammatory monocytes that were dependent on 
excessive production of GM-CSF and IL-22. Moreover, 
NKp46+ILC3s were sufficient to induce inflammation in this 
model, demonstrating a nonredundant inflammatory func-
tion that was partially caused by their enhanced capacity to 
secrete GM-CSF in vivo. We also examined ILC3-deficient 
mouse lines in host defense against C. rodentium. ILC3s were 
essential in T cell–deficient mice but partially redundant in 
T cell–competent mice. However, the NKp46+ILC3 subset 
was always redundant, both in T cell–competent and T cell–
deficient mice. In conclusion, NKp46+ILC3s have a unique 
role in GM-CSF–mediated recruitment and activation of in-
flammatory monocytes during innate intestinal inflammation, 
but are redundant for clearance of C. rodentium, whether T cells 
are present or absent.
RESULTS
Generation of mice that lack all ILC3s and NKp46+ILC3s
We identified ILC3s in mouse intestine as CD45+Lin–
Thy1+RORt+ cells. As previously shown (Vonarbourg et al., 
2010), ILC3s were generally more abundant in the small in-
testine than in cecum and colon (Fig. S1 A). Based on NKp46 
expression, ILC3s were distinguished into NKp46+ILC3s and 
LTi-like ILC3s (NKp46–) subsets. LTi-like ILC3s subsets were 
further divided in CCR6+ and CCR6– subsets (Fig. S1 A and 
not depicted; Diefenbach et al., 2014; Eberl et al., 2015). 
To engineer mice with specific deletions of ILC3s, we crossed 
Ahrf/f mice to Rorc(t)-cre mice (AR mice) and Rorc(t)f/f mice 
to NKp46-cre mice (RN mice). AR mice had a marked re-
duction of all ILC3s (Fig. S1 B). Moreover, because RORt 
is transiently expressed during thymic lymphocyte develop-
ment, AR mice also lacked AHR in T cells (unpublished data), 
which may affect some functions of TH17 and TH22 cells, 
including IL-22 secretion, in vitro but not in vivo (Martin et al., 
2009; Duarte et al., 2013; Qiu et al., 2013; unpublished data). 
RN mice selectively lack NKp46+ILC3s (which also include 
ex-RORt+ ILC3s; Fig. S1 B) and, therefore, are suitable to 
study the functions of NKp46+ILC3s in otherwise immuno-
competent mice. AR and RN mice were then crossed with 
Tcrb/Tcrd/ (Tcrbd/) mice to obtain mice that lack ILC3s 
and T cells (ART mice; Fig. S1, C and D), or NKp46+ILC3s 
and sustaining the tolerogenic function of intestinal DCs 
through GM-CSF secretion (Mortha et al., 2014). Further-
more, ILC3s control T cell–dependent and –independent IgA 
production through lymphotoxins (Kruglov et al., 2013), as 
well as marginal zone B cell Ig production (Magri et al., 2014). 
ILC3s can also protect intestinal stem cells from immune-
mediated tissue damage in graft versus host disease (Dudakov 
et al., 2015). In some cases, ILC3s have deleterious roles. For 
example, ILC3s have been implicated in Helicobacter hepaticus–
driven innate colitis, which is associated with an increased 
production of IL-17 and IFN- in the colon (Buonocore 
et al., 2010). Inappropriate activation of ILC3s has also been 
shown to induce intestinal damage through excessive IL-22–
induced production of neutrophil chemoattractants by epi-
thelial cells, resulting in accumulation of neutrophils and 
tissue destruction (Eken et al., 2014).
In mice, ILC3s include two major subsets (Diefenbach 
et al., 2014; Eberl et al., 2015). Lymphoid tissue-inducer (LTi)-
like ILC3s have phenotypic features overlapping with those of 
fetal LTi cells that promote lymphoid organogenesis, including 
lack of lineage markers along with expression of CD127 and 
lymphotoxins. Some cells within this subset express the che-
mokine receptor CCR6 and are thought to have a distinct 
progenitor from CCR6– LTi-like ILC3s (Vonarbourg et al., 
2010; Constantinides et al., 2014; Klose et al., 2014). However, 
both CCR6+ and CCR6– ILC3s require RORt and AHR 
for development. NKp46+ILC3s express the NK cell marker 
NKp46 in addition to CD127 and require AHR (Kiss et al., 
2011; Lee et al., 2012; Qiu et al., 2012), Notch (Lee et al., 2012) 
and T-bet for development (Sciumé et al., 2012; Klose et al., 
2013; Rankin et al., 2013b). Under certain inflammatory con-
ditions, NKp46+ILC3s down-regulate expression of RORt, 
increase T-bet expression and become a source of IFN- 
(Vonarbourg et al., 2010). These cells, known as ex-RORt 
ILC3s, may contribute to host-defense against certain bacterial 
infections, such as Salmonella thyphymurium (Klose et al., 2013). 
LTi-like and NKp46+ILC3s also differ in their distribution 
within the intestine; LTi-like ILC3s are found throughout the 
intestine in association with lymphoid follicles; NKp46+ILC3s 
are diffuse in the lamina propria and their distribution is de-
pendent on the expression of the chemokine receptor CXCR6 
(Satoh-Takayama et al., 2014). Notably, LTi-like ILC3s and 
NKp46+ ILC3s share expression of some core genes compared 
with other ILCs, such as IL-22, but are also transcriptionally 
distinct (Reynders et al., 2011; Robinette et al., 2015).
To date, it is unclear whether NKp46+ and LTi-like ILC3 
subsets are redundant or have specialized functions. Moreover, 
the functions of NKp46+ and LTi-like ILC3s have been fre-
quently examined in immunodeficient mice that lack adap-
tive responses. To address these gaps in our understanding of 
ILC biology, we examined novel mouse lines that lack ILC3s. 
RORt- and AHR-deficient mice lack ILC3s and have been 
used as ILC3-deficient models. These transcription factors, 
however, function in a variety of cells types, including other 
lymphocytes and nonhematopoietic populations, making 
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depicted), whereas there was no difference between neutro-
phils and inflammatory monocytes in untreated mice (unpub-
lished data). Intestinal CD11c+ DCs (including CD11b+ 
and CD11b– subsets) and CD11c–CD11b+ macrophages were 
found at similar frequencies in the colons of Tcrbd/ and 
ART mice, both before and after anti-CD40 (Fig. 2 B and 
not depicted).
We also assessed the capacity of intestinal myeloid cells to 
produce inflammatory cytokines. In Tcrbd/ mice injected 
with anti-CD40, both neutrophils and inflammatory mono-
cytes produced IL-1 and TNF at day 7 p.i.; inflammatory 
monocytes also produced IL-6 (unpublished data). DC and 
resident macrophages produced small amounts of these cyto-
kines. A marked reduction in cytokine production by inflam-
matory monocytes, but not neutrophils, was noted in ART 
mice (unpublished data). These data indicate that lack of 
ILC3s results in accumulation of fewer neutrophils and in-
flammatory monocytes, which is consistent with the reduced 
intestinal content of CXCL1, CCL2, GM-CSF, and G-CSF 
observed in ART mice (Fig. 1, D and E). Moreover, lack of 
ILC3s selectively diminishes cytokine secretion by inflamma-
tory monocytes, most likely due to reduced availability of 
GM-CSF (Fig. 1 D), which has been shown to promote 
monocytic functions (Griseri et al., 2012). We conclude that 
ILC3s have an important function in recruiting and activating 
Ly6C+ inflammatory monocytes in the absence of T cells.
Adoptive transfer of intestinal ILC3s into lymphopenic mice 
is sufficient to enable innate immune colitis
To corroborate the proinflammatory function of ILC3s in 
anti-CD40 colitis we performed adoptive transfer experi-
ments. We isolated ILC3s from the small intestine of Rag1/ 
mice (unpublished data), transferred them into NOD/SCID 
x c/ (NSG) mice, and waited 2 or 8 wk to allow cells to 
repopulate the intestine. Next, we induced colitis by injection 
of anti-CD40 and examined weight loss and intestinal pa-
thology after 1 wk. NSG mice reconstituted with ILC3s for 
8 wk quickly lost weight and remained underweight for the 
duration of the experiment (Fig. 3 A). In these mice, ILC3s 
reconstituted the intestine, whereas no ILC3s were detected 
in the spleen (Fig. 3 B). Weight loss was paralleled by a signifi-
cant recruitment of neutrophils and inflammatory monocytes 
(Fig. 3, C and D). In contrast, NSG mice that had not been 
reconstituted or were reconstituted only for 2 wk before coli-
tis induction showed no weight loss, absence of ILC3s in the 
intestine or spleen, and no intestinal recruitment of neutro-
phils or monocytes (unpublished data). These results conclu-
sively demonstrate a proinflammatory function for ILC3s 
in anti-CD40–induced colitis.
Depletion of inflammatory monocytes protects mice from 
anti-CD40–induced colitis
Our data suggested that ILC3s promote intestinal inflamma-
tion by inducing recruitment and activation of both neu-
trophils and inflammatory monocytes, which may work in 
concert to drive inflammation and tissue damage. To test this 
and T cells (RNT mice; Fig. S1 C and S1 D). Thus, AR, RN, 
ART and RNT mice can be used to parse unique and redun-
dant functions of ILC3s and T cells, while preserving B cells 
in all mice.
Lack of ILC3s curbs intestinal inflammation  
in anti–CD40-induced colitis
To explore the role of ILC3s in intestinal inflammation, we 
used a model of colitis induced by injection of anti-CD40 
into mice that lack adaptive immunity, such as Rag1-deficient 
mice (Uhlig et al., 2006). In this model, anti-CD40 causes in-
appropriate and unrestricted activation of myeloid cells, lead-
ing to massive release of inflammatory cytokines. Colitis and 
mucosal immunopathology depend on IL-23, whereas IL-12 
promotes wasting disease and elevation of serum inflamma-
tory mediators. Although the anti-CD40 model is usually 
performed in Rag-deficient mice that lack both T and B cells, 
we chose to examine the role of ILC3 in Tcrbd/ mice, 
which lack T cells but are B cell competent. After anti-CD40 
injection, Tcrbd/ mice quickly lost body weight and remained 
severely underweight for the duration of the experiment (7 d; 
Fig. 1 A). In contrast, ART mice lost less weight and quickly 
recovered, beginning at day 4. At day 7 after treatment, less 
pronounced colonic shortening and milder histopathology 
was evident in ART mice than in Tcrbd/ mice (Fig. 1, 
B and C), whereas there was no difference between Tcrbd/ 
and ART naive animals (unpublished data).
A marked increase in IL-22, the inflammatory mediator 
S100A8, the enzyme NOS2 that produces nitric oxide, 
as well as many inflammatory cytokines, such as IL-17a/f, 
IFN-, TNF, IL-1, IL-23p19, IL-12p40, and IL-6, was 
obvious in the intestines of Tcrbd/ mice injected with 
anti-CD40 (Fig. 1, D and E). Notably, IL-12p35 expression 
was not elevated, indicating a more predominant patho-
genic role for IL-23 than for IL-12 in intestinal inflamma-
tion. Chemoattractants and growth factors for neutrophils 
and inflammatory monocytes, such as CXCL1, CCL2, G-CSF, 
and GM-CSF, were also increased. The induction in in-
flammatory mediators was paralleled by an increase of 
IL-10, which may reflect the activation of feedback mecha-
nisms for reducing inflammation. Lower amounts of all 
these cytokines and chemokines were detected in the intes-
tines of ART mice in comparison with the Tcrbd/ mice 
(Fig. 1, D and E). We conclude that ART mice exhibit signifi-
cantly less clinical, pathological, and biochemical features of 
intestinal inflammation than do Tcrbd/ mice after admin-
istration of anti-CD40.
Lack of ILC3s curtails intestinal accumulation of Ly6C+ 
monocytes and neutrophils
Upon induction of anti-CD40–mediated colitis, CD11b+Ly6G+ 
neutrophils and CD11b+Ly6G–Ly6C+ monocytes accumu-
lated in the intestines of Tcrbd/ mice, peaked at day 4 in the 
small intestine and sustained up to day 7 in the colon (Fig. 2 A). 
ART mice had fewer intestinal neutrophils and inflamma-
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Figure 1. ILC3 deficiency protects mice from anti-CD40–induced colitis. ART and Tcrbd/ mice were injected with anti-CD40. (A) Mice were 
weighed daily, from day 0 to 7 p.i. (B) Colons were harvested and overall lengths measured 7 d p.i. Colon lengths were also assessed in Ahrf/f x Tcrbd/ 
(flox control mice) and Rort-cre x Tcrbd/ (Cre control mice; not depicted). A and B represent five independent experiments with 4–10 mice/group per 
experiment. (C) Colons were stained with hematoxylin and eosin and scored for severity of colitis on day 7, where a higher score corresponds to increased 
pathology. Data represent two independent experiments with four to five mice/group. (D) mRNA expression of inflammatory mediators. Colons were col-
lected from ART and Tcrbd/ mice at day 4 and 7 after anti-CD40 injection and the indicated transcripts were measured via quantitative RT-PCR. All 
gene expression values were normalized to Gapdh. (E) Protein expression of inflammatory mediators. Colonic lamina propria was processed at day 7 after 
anti-CD40 treatment; 106 cells were isolated and cultured for 4 h. The indicated cytokines were measured by cytometric bead array of the culture super-
natants. (D and E) Data represent two independent experiments with five mice/group. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, Student’s  
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the antibody. These results suggested that neutrophils are 
not critical in inducing intestinal inflammation during anti-
CD40–induced colitis, but instead, that inflammatory mono-
cytes may be important.
To test this hypothesis, we tried to selectively deplete in-
flammatory monocytes using an antibody for CCR2 (MC-
21), which is a selective marker of these cells (Shi and Pamer, 
2011). Anti-CCR2–treated mice had less severe disease, lost 
less body weight, and recovered faster than did mice treated 
with a control antibody (Fig. 4 B). As expected, anti-CCR2 
treatment resulted in significantly lower numbers of intestinal 
hypothesis, we attempted to deplete both cell types by using 
an anti-Ly6G/Ly6C (GR1) antibody (Daley et al., 2008). 
We found that administration of the antibody had no protec-
tive effect, as disease severity was unchanged compared with 
control treatment (Fig. 4 A). However, a close examination 
of the depleting efficacy of anti-GR1 administration re-
vealed that this antibody successfully depleted both neu-
trophils and inflammatory monocytes in blood and spleen 
(not depicted), whereas only neutrophils were effectively de-
pleted in the intestine (Fig. 4 A). Inflammatory monocytes 
persisted in the intestine even after 5 d of daily injections of 
Figure 2. Evaluation of intestinal myeloid populations in ART and Tcrbd/ mice treated with anti-CD40. (A) Tcrbd/ mice were treated with 
anti-CD40 and sacrificed at days 0, 4, and 7. Cells were purified from colonic and small intestinal lamina propria. Ly6G+ neutrophils and Ly6G–Ly6Chi in-
flammatory monocytes were distinguished within the population of live CD45+CD19–CD11b+ cells. Representative plots (top) and neutrophil and mono-
cyte numbers among 106 total leukocytes (bottom) are indicated. Data represent three independent experiments with two mice/time point. (B) Colonic 
lamina propria cells from Tcrbd/ and ART mice were collected at day 7 after anti-CD40 treatment. Live, CD45+CD19– cells were analyzed for expression 
of Ly6G, Ly6C, CD11c, and CD11b. Data represent five independent experiments with two mice/group. Representative plots (top) and total numbers of 
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inflammatory monocytes (Fig. 4 B). However, anti-CCR2–
treated mice also had fewer intestinal neutrophils. Given 
that CCR2 is not expressed by neutrophils, it is likely that 
this reduction is secondary to diminished accumulation 
of inflammatory monocytes, which are known to release 
cytokines and chemokines that recruit neutrophils, such as 
IL-1 (Rogers et al., 1994). To definitively assess the con-
tribution of neutrophils to anti-CD40–induced colitis, we 
selectively depleted neutrophils using an anti-Ly6G anti-
body. We found that neutrophil depletion did not attenuate 
disease severity (Fig. 4 C). Our results indicate that inflam-
matory monocytes have a predominant pathogenic role 
over neutrophils in anti-CD40–induced colitis and, there-
fore, ILC3s may promote colitis primarily by inducing 
accumulation and activation of inflammatory monocytes 
in the intestine.
Neutralization of GM-CSF and IL-22 ameliorates  
anti-CD40–induced colitis
We asked how ILC3s drive accumulation of Ly6C+ mono-
cytes in the intestine and promote subsequent inflammation. 
We and others have previously shown that ILC3s produce 
GM-CSF (Cella et al., 2009; Mortha et al., 2014). Moreover, 
it has been shown that GM-CSF drives extramedullary 
expansion of inflammatory monocytes from granulocyte-
monocyte progenitors (GMPs) during inflammation (Griseri 
et al., 2012). Based on these data and the finding that 
GM-CSF was substantially reduced in ART mice compared 
with Tcrbd/ controls (Fig. 1 D) after anti-CD40 injection, 
we hypothesized that ILC3s drive colitis by producing GM-
CSF required for the expansion, survival, and function of 
inflammatory monocytes. Consistent with this hypothesis, 
we observed that anti-CD40 induced robust production of 
GM-CSF by ILC3s, particularly by NKp46+ILC3s (Fig. 5 A). 
We next assessed disease severity and accumulation of Ly6C+ 
monocytes during anti-CD40–induced colitis in Tcrbd/ 
mice treated with an anti–GM-CSF–neutralizing antibody. 
Tcrbd/ mice receiving anti–GM-CSF recovered as quickly 
as ART mice, whereas Tcrbd/ treated with a control anti-
body showed persistent weight loss (Fig. 5 B). Recovery 
was paralleled by a significant reduction of intestinal Ly6C+ 
monocytes (Fig. 5, C and D).
Because all ILC3s produce IL-22, which can promote 
inflammation by stimulating epithelial cell secretion of 
chemoattractants for myeloid cells (Ouyang et al., 2008), 
we asked whether IL-22 has a pathogenic role in this 
model. Neutralization of IL-22 with a specific antibody re-
duced the severity of anti-CD40–induced colitis (Fig. 5 B) 
and the accumulation of Ly6C+ monocytes (Fig. 5 C) to a 
degree similar though significantly less than anti-GM-
CSF (Fig. 5 D). We conclude that ILC3s promote colitis 
through secretion of GM-CSF and IL-22. GM-CSF di-
rectly promotes the accumulation of inflammatory myeloid 
cells; IL-22 likely acts indirectly, by stimulating epithelial 
cells to secrete myeloid cell chemoattractants (Ouyang 
et al., 2008).
Figure 3. Adoptively transferred ILC3s cause severe colitis in 
NSG mice. 2 × 104 small intestinal ILC3s (CD45+Lin–Thy1+CD127+ 
cells) sort-purified from Rag1/ mice were intravenously injected 
into NSG mice. (A) After 8 wk, mice were treated with anti-CD40, and 
body weights were measured daily, from 0 to 7 d p.i. Data represent 
two independent experiments with four mice/group. (B) Cells were 
purified from the small intestinal lamina propria. ILC3s were identified 
as CD45+LinThy1+RORt+ cells. Data represent three independent 
experiments with two mice/group. (C) Ly6G+ neutrophils and Ly6G–
Ly6Chi inflammatory monocytes were distinguished within the popula-
tion of live CD45+CD19–CD11b+ cells and (D) absolute numbers 
quantified. Data are representative of three experiments with two 
mice/group (C) or two independent experiments with five mice/group (D). 
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content of IL-22, S100A8, NOS2, IL-17F, IFN-, TNF, 
IL-1, IL-6, and GM-CSF in the small intestine of RNT 
mice was markedly lower than in Tcrbd/ mice (Fig. 6 D). 
Consistent with the presence of fewer NKp46+ILC3s in the 
colon than small intestine and less efficient depletion in this 
organ (Fig. S1 D), reduction of NKp46+ILC3s in RNT mice 
had less impact on many inflammatory mediators, which 
remained elevated (Fig. 6 E). However, GM-CSF was sig-
nificantly reduced in colon, as were indicators of epithelia 
cell inflammation, such as S100A8 and NOS2. To test the 
differential ability of NKp46+ILC3s and LTi-like ILC3s to 
Lack of NKp46+ILC3s is sufficient to protect mice from 
anti-CD40–induced colitis
To determine whether NKp46+ and LTi-like ILC3s have 
unique or redundant roles in the pathogenesis of intestinal 
inflammation induced by anti-CD40, we examined the anti-
CD40 model in RNT mice. After anti-CD40 injection, re-
markably, RNT mice phenocopied the ART mice: they lost 
less weight and recovered earlier than Tcrbd/ mice (Fig. 6 A). 
Moreover, RNT mice exhibited less colonic shortening than 
Tcrbd/ mice (Fig. 6 B). Recruitment of neutrophils and 
inflammatory monocytes was also reduced (Fig. 6 C). The 
Figure 4. Impact of inflammatory monocytes and neutrophils depletion on anti-CD40–induced colitis. Tcrbd/ mice were treated with (A) 
anti-GR1 (RB6-8C5) or control IgG at days 1, 1, 3, and 5; (B) anti-CCR2 (MC-21) or control IgG at days 4, 1, 2, 3, and 4; (C) anti-Ly6G (1A8), or con-
trol IgG at days 1, 1, 3, and 5. Anti-CD40 was injected at day 0. (A–C) Numbers of intestinal neutrophils and inflammatory monocytes among 106 total 
leukocytes present in the colon are indicated for each antibody treatment to indicate the efficacy of depletion. *, P < 0.05; ***, P < 0.001, Student’s t test. 
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function and preventing bacterial translocation, at least in 
T cell–deficient mice.
Partial redundancy of ILC3s and T cells in C. rodentium 
infection
Many studies in mice have demonstrated that ILC3s mediate 
protection from C. rodentium infection, mainly through the 
production of IL-22. However, most of these studies have ex-
amined the impact of ILC3s in immunodeficient mice, like 
Rag-deficient mice, which lack important adaptive sources of 
IL-22, such as TH17, TH22, and  T cells (Sutton et al., 
2009). Moreover, the role of ILC3s has been frequently as-
sessed by anti-Thy1–mediated depletion, a method that de-
pletes all ILCs and NK cells. To assess the specific contributions 
of ILC3s, particularly NKp46+ILC3s, and T cells during 
C. rodentium infection, we compared WT, AR, NR, ART, RNT, 
and Tcrbd/ mice. As expected, AR infected with C. roden-
tium lost weight and 50% died by day 35 p.i., whereas WT 
mice were resistant to infection (Fig. 7 A). Because AR mice 
lack ILC3s but may also have defects in TH17 and TH22 cells, 
we attributed this susceptibility to concurrent deficits in 
ILC3s and T cells. However, RN mice were resistant to infec-
tion, just like WT control mice, suggesting that NKp46+ILC3s 
specifically induce colitis, we isolated both subsets and inde-
pendently transferred them into NSG mice, as we had previ-
ously done with bulk ILC3s. NSG mice reconstituted with 
NKp46+ILC3s lost more weight than mice reconstituted 
with NKp46– ILC3s (Fig. 6 F). Thus, lack of NKp46+ILC3s is 
necessary and sufficient to protect mice from anti-CD40–
induced colitis, suggesting a crucial role of NKp46+ILC3s 
in intestinal inflammation due to inappropriate secretion of 
GM-CSF and, in part, IL-22 and subsequent activation and 
recruitment of inflammatory monocytes.
Given the robust and unregulated inflammation in the 
anti-CD40 model, it possible that the physiological role of 
ILC3s as a mucosal sentinels via their production of IL-22 
and GM-CSF become hijacked and improperly proinflam-
matory. Indeed, we noticed that ART and NRT mice in-
jected with anti-CD40 have larger and heavier spleens 
than Tcrbd/ mice (unpublished data). We also detected 
bacterial growth in the spleens of ART and RNT mice but 
not Tcrbd/ mice (unpublished data), which corresponded 
to higher serum levels of TNF and IFN- (unpublished 
data). These results suggest that although ILC3s have delete-
rious local effects during inappropriate intestinal inflamma-
tion, they may be important for maintaining intestinal barrier 
Figure 5. Impact of GM-CSF and IL-22 neutralization on anti-CD40–induced colitis. (A) Representative plots show intracellular content of  
GM-CSF in LTi-like ILC3s (NKp46–) and NKp46+ILC3s isolated from the small intestines of Tcrbd/ and ART mice, 6 d after treatment with anti-CD40. 
Cells were surface stained to identify NKp46+ and NKp46 ILC3s; GM-CSF and TNF content were determined after 4-h culture in the presence of monen-
sin. Data represent three independent experiments with two mice/group. (B and C) Tcrbd/ mice were treated with anti–GM-CSF (MP1-22E9), anti–IL-22 
(8E11), or control IgG at days 0, 2, 4, and 6. ART mice received no neutralizing antibodies. Anti-CD40 was injected into all mice at day 0. (B) Mice were 
weighed daily, from 0 to 7 d p.i. Data represent three independent experiments with five mice/group. (C) Representative plots of intestinal inflammatory 
monocytes present in the colon of antibody-treated mice. (D) Quantification of inflammatory monocytes as represented in (C). C and D represent three 
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100% mortality by day 20 (Fig. 7 C). Thus, both T cells and 
ILC3s contribute to antibacterial defense. Conversely, RNT 
mice and Tcrbd/ controls were equally susceptible to 
C. rodentium infection (Fig. 7 D); body weight loss and mortality 
post-infection overlapped in RNT and Tcrbd/ mice. Thus, 
NKp46+ILC3s alone are not required to resist C. rodentium 
are unnecessary to control C. rodentium in the presence of 
T cells (Fig. 7 B). To tease apart the contributions of ILC3s 
and T cells, we further analyzed Tcrbd/, ART, and RNT 
mice. Tcrbd/ mice were highly susceptible to infection, with 
marked weight loss and 100% mortality at ~ day 40 p.i.; in 
comparison, ART mice had accelerated body weight loss and 
Figure 6. Lack of NKp46+ ILC3s curbs inflammation during anti-CD40–induced colitis. RNT and Tcrbd/ mice were injected with anti-CD40.  
(A) Mice were weighed daily after antibody administration. Data represent five independent experiments with five mice/group. (B) Colons from Tcrbd/ 
and RNT mice were isolated 7 d after anti-CD40 injection and total lengths measured. Data represent three independent experiments with four to five 
mice/group. (C) Cells were purified from the small intestine LP. Ly6G+ neutrophils and Ly6G–Ly6Chi inflammatory monocytes were distinguished within the 
population of live CD45+CD19–CD11b+ cells. Representative plots (left) and total neutrophil and monocyte numbers among 106 total leukocytes (right) are 
indicated. Data represent three independent experiments with two mice/group. Small intestines (D) and colons (E) were collected at day 7 after anti-CD40 
injection, RNA was extracted and cytokine content was measured by quantitative RT-PCR. Y axis demonstrates relative transcript abundance and x axis 
shows day p.i. Data in D and E represent three independent experiments with five mice/group (F) NKp46+ ILC3 (CD45+Thy1+CD127+NK1.1–KLRG1–NKp46+) 
and LTi-like ILC3 (CD45+Thy1+CD127+ NK1.1–KLRG1–NKp46–) subsets from small intestine lamina propria were sort purified from Rag1/ mice and intra-
venously injected into NSG mice. After 8 wk, mice were treated with anti-CD40, and body weights were measured daily, from 0 to 7 d p.i. Data represent 
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challenge even in the absence of T cells, presumably because 
LTi-like ILC3s provide sufficient protection.
We more broadly investigated the mechanisms by which 
ILC3s contribute to C. rodentium susceptibility in ART mice. 
ART mice had markedly less IL-22 in the colon at day 7 p.i. 
than did Tcrbd/ mice. Levels of IL-17A/F, IFN-, and 
GM-CSF were also reduced in the colons of ART mice 
(Fig. 7 E). Furthermore, significantly fewer CD11b+Ly6G+ 
neutrophils accumulated in the colons of ART mice than 
in the colons of Tcrbd/ mice after C. rodentium infection 
(unpublished data). Because neutrophils are known to be 
important mediators of C. rodentium clearance (Wang et al., 
2010; Kamada et al., 2015), we focused on the potential 
impact of limited neutrophil accumulation in ART mice 
on the outcome of infection. Depletion of neutrophils in 
Tcrbd/ mice using anti-Ly6G (1A8) during C. rodentium 
infection caused increased disease severity, recapitulating the 
phenotype seen in ART mice (Fig. 7 F). Thus, ILC3s con-
tribute to protection against C. rodentium infection in Tcrbd/ 
by promoting neutrophil accumulation. We conclude that 
functionally competent ILC3s are essential to resist C. rodentium 
when T cell responses are also compromised. When T cells 
are present, ILC3s have limited impact and NKp46+ILC3s 
are dispensable.
DISCUSSION
NKp46+ and LTi-like ILC3s are two distinct subsets of 
ILC3s that have been shown to diverge in their develop-
ment. Although both subsets depend on RORt and AHR, 
NKp46+ILC3s also require Notch and T-bet, whereas LTi-like 
ILC3s do not. Because NKp46+ILC3s express both RORt 
and T-bet, they have functional plasticity such that, under 
certain conditions, they down-regulate RORt, up-regulate 
T-bet, and produce IFN- (Klose et al., 2013; Rankin et al., 
2013b). Despite the knowledge that ILC3 subsets develop-
mentally and transcriptionally diverge, it remains unclear the 
extent to which they are functionally distinct. Our study ad-
vances the functional characterization of NKp46+ILC3s by 
demonstrating their capacity to secrete GM-CSF and pro-
mote the accumulation and activation of inflammatory mono-
cytes. This functional property of NKp46+ILC3s is evident 
in the anti-CD40 model of colitis, as demonstrated by the 
marked intracellular content of GM-CSF in NKp46+ILC3s, 
as well as the reduction of disease severity after deletion of 
NKp46+ILC3s in RNT mice or neutralization of GM-CSF 
in Tcrbd/ mice. Thus, NKp46+ILC3s are necessary and suf-
ficient to induce intestinal pathology when inappropriately 
Figure 7. Contribution of ILC3s to defense against C. rodentium 
infection. (A–D) C. rodentium (2 × 109) was administrated by oral gavage 
to 8–12-wk-old B6 (A and B), AR (A), RN (B), Tcrbd/ (C and D), ART (C), 
and RNT (D) mice. Body weight and survival were monitored from 0 to  
40 d p.i. (A–D) Data represent at least three independent experiments with 
5–10 mice/group. (E) RNA was isolated from colons of Tcrbd/ and ART 
mice at day 7 after injection; Il22, Il17a, Il17f, Ifng, and Csf2 were mea-
sured by RT-PCR. All gene expression values were normalized to Gapdh. 
Data represent three independent experiments with five mice/group.  
(F) Neutrophil depletion in Tcrbd/ mice accelerates lethality to C. roden-
tium infection. Mice were infected and neutrophil depletion performed 
every 3 d by administration of 100 µg of anti-Ly6G (1A8) antibody.  
(E and F) Data are representative of three independent experiments with 
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ILC1s. Thus, our study highlights that a spectrum of ILC 
subsets contribute to anti-CD40 colitis, perhaps through con-
version, as well as independent functions. Moreover, both of 
the aforementioned studies indicate that colitis is induced by 
IFN-–producing cells (Buonocore et al., 2010; Vonarbourg 
et al., 2010), which may be an additional mechanism beside 
the pathogenic role of ILC3-derived GM-CSF that we 
identified here.
Remarkably, neutralization of IL-22 also eased disease se-
verity in this colitis model. Thus, although IL-22 is generally 
thought to have a protective function on the intestinal mu-
cosa, our results indicate that in some circumstances IL-22 
promotes inflammation. IL-22 was recently shown to induce 
transcription of IL-18 in epithelial cells (Muñoz et al., 2015). 
Our own data suggest that IL-22 may also induce transcrip-
tion of IL-33 (unpublished data). Moreover, IL-22 stimulates 
epithelial cells to produce chemokines that attract myeloid 
cells (Rutz et al., 2014). Finally, IL-22 activates STAT3, a 
transcription factor induced by many inflammatory cytokines 
that has been implicated in chronic inflammation and cancer 
(Ghoreschi et al., 2011). Thus, IL-22 may cause inflamma-
tion, perhaps when it is secreted in excess and/or acts in 
concert with other stimuli that activate IL-18, IL-33, and 
myeloid cells. The pathogenic function of IL-22 in the anti-
CD40 model is also consistent with results from a different 
model of colitis induced by adoptive transfer of T reg cell-
depleted CD45RBlo memory T cells into Rag-deficient mice 
(Kamanaka et al., 2011). Elucidating how this dual function-
ality of IL-22 is achieved may lead to a better understanding 
of inflammatory bowel diseases.
In contrast to their pathogenic role in anti-CD40 colitis, 
neither NKp46+ILC3s nor ILC3s in general had an impact 
on the course of DSS-induced colitis (unpublished data), 
whether it was induced in immunocompetent or T cell–
depleted mice. DSS treatment damages the intestinal epithe-
lium, thereby exposing immune cells of the lamina propria to 
the intestinal microbiota and its products. It is possible that 
DSS-induced colitis is relatively independent of GM-CSF–
mediated activation of inflammatory monocytes and that 
other pathways, such as activation of local macrophages or 
other cells of the innate immune system by intestinal microbiota, 
are predominant in this model.
Given that many studies have focused on the role of 
ILCs in immunocompromised mice, particularly Rag-deficient 
mice, it remains largely unclear the extent to which many 
ILCs have unique functions apart from T cells and B cells. 
Our study parses the role of ILC3s and T cells, both of which 
provide important sources of IL-22 for antibacterial defense, 
in host defense against C. rodentium infection in the presence 
of B cells. We found that ILC3s have a marked impact on 
host defense when T cells are absent, consistent with pre-
vious studies (Sonnenberg et al., 2011; Basu et al., 2012). 
However, whereas ART mice were more susceptible to in-
fection than Tcrbd/ mice, RNT mice and Tcrbd/ mice 
were equally susceptible, suggesting that LTi-like ILC3s 
are sufficient to control C. rodentium infection, whereas the 
activated. A previous study showed that IL-1 stimulates 
ILC3s to produce GM-CSF (Mortha et al., 2014). However, 
incubation of NKp46+ILC3s with IL-1 was not sufficient to 
elicit GM-CSF in vitro. Similarly, human CD56+NKp44+ILC3s 
did not secrete GM-CSF in response to IL-1 (unpublished 
data). Given these data, we postulate that induction of GM-CSF 
secretion requires multiple cytokines, including those induced 
by anti-CD40 stimulation of myeloid cells, rather than a sin-
gle cytokine. Engagement of one or more cell surface recep-
tors on NKp46+ILC3s, including NKp46, may also contribute 
to GM-CSF secretion.
GM-CSF and inflammatory monocytes have been iden-
tified as the culprits mediating tissue damage in a model 
of experimental autoimmune encephalomyelitis (Becher and 
Segal, 2011). Moreover, GM-CSF was shown to promote 
disease in a T cell transfer model of colitis by inducing ex-
cessive accumulation of granulocyte-monocyte progenitors 
(GMP) and consequent extramedullary production of neu-
trophils and inflammatory monocytes (Griseri et al., 2012). 
Inflammatory monocytes, in turn, promote tissue damage 
and dysbiosis (Zigmond et al., 2012; Seo et al., 2015). Our 
study shows, for the first time, that the pathogenesis of anti-
CD40–induced innate immune colitis is also GM-CSF de-
pendent. GM-CSF acts primarily by recruiting and activating 
inflammatory monocytes. We used CCR2 depletion and 
GM-CSF neutralization experiments to this end. A previous 
study proposed that ILC3s cause intestinal damage in the 
anti-CD40 model of colitis by recruiting neutrophils (Eken 
et al., 2014). We also observed that ILC3s induce neutrophil 
accumulation by stimulating the release of neutrophil che-
moattractants by monocytes and epithelial cells. However, 
neutrophil depletion had no impact on colitis, which suggests 
that inflammatory monocytes dominate the pathogenic pro-
cess. Because inflammatory monocytes provide an important 
source of IL-23 and IL-1 that stimulate ILC3s (Cella et al., 
2009; Longman et al., 2014), recruitment of inflammatory 
monocytes likely generates a positive feedback loop that am-
plifies inflammation. Notably, this inflammation may reflect 
the physiological function of ILC3 to maintain epithelial ho-
meostasis and support wound healing, which is hijacked in 
immunocompromised mice by a strong activating inflamma-
tory stimulus such as CD40 cross-linking.
Our study genetically defines NKp46+ILC3s as a colito-
genic cell subset in the anti-CD40–induced model. A previ-
ous study by Buonocore et al. (2010) showed that colitis is 
induced by a colonic NKp46 Thy1+ Sca1high subset that 
is probably unrelated to the ILC subsets that we examined, as 
in our experiments colitogenic cells are primarily NKp46+ 
RORt+ ILC3s. In another study, Vonarbourg et al. (2010) 
indicated that NKp46+ RORt cells can induce colitis after 
adoptive transfer. These cells include RORt+ cells that have 
converted into RORt cells (ex-RORt cells), but may 
also include ILC1s and perhaps NK cells. By deleting NKp46+ 
Rort+ cells in RNT mice, we also eliminate ex-RORt 
NKp46+ cells (which represent 30–50% of NKp46+NK1.1+ 
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Histology. Colons were washed with PBS, and fixed in 10% phosphate-
buffered formalin overnight and then transferred to 70% ethanol. Fixed tis-
sues were then paraffin-embedded, sectioned, and stained with hematoxylin 
and eosin (H&E). Severity of inflammation was scored blinded, as previously 
described. Two intestinal pieces from the same mouse were scored and the 
cumulative score is plotted (Satpathy et al., 2013).
Depletions. Tcrbd/ mice were injected i.p. with either 20 µg of anti-CCR2 
(MC-21) daily, 200 µg of anti-Ly6G (1A8) every other day, 100 µg of anti-GR1 
(RB6-8C5) every other day, or control IgG. Anti-CD40 was injected at day 0. 
Anti–GM-CSF (MPI-22E9) and anti–IL-22 (8E11) used for neutralization 
experiments were obtained from Bioxcell and Genentech, respectively. 
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NKp46+ILC3s are redundant. Perhaps LTi-like ILC3s are 
sufficient because they are strategically located close to sites 
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C. rodentium infection. Collectively, our results suggest that it 
will be important in the future to assess the role of ILCs in 
mice with intact T and B cell responses.
In conclusion, we have identified nonredundant and re-
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 Figure S1. Gating strategy for ILC3 subsets in B6, AR, RN, ART, RNT, and Tcrbd   /   mice . (A) Representative plots of ILC3 subsets in the small intestinal, cecal, and 
colonic LP of B6 mice. Live CD45+Lin2Rorgt+Thy1+ cells were gated and analyzed for expression of CCR6 and NKp46. (B) Total numbers of LTi-like ILC3s (CCR6+NKp46   and 
CCR6  NKp46  ) and NKp46+ ILC3s, among 106 total leukocytes, found in the small intestinal, cecal, and colonic LP. (C) Representative plots of ILC3 subsets in the small intestinal, 
cecal, and colonic LP of Tcrbd   /   mice. (D) Numbers of LTi-like ILC3s (CCR6  NKp46   and CCR6+NKp46  ) and NKp46+ ILC3s (CCR6  NKp46+) found in the small intestinal, cecal, 
and colonic LP of Tcrbd   /   , ART, and RNT mice. Data are representative of four mice/group. *, P < 0.05; **, P < 0.01; ***, P < 0.001, Student’s t test. Bars represent mean ± SEM. 
